Glp1
-
{
- All
- News
-
Ozempic, Wegovy And Zepbound May Cause Vision Loss? Indian Doctors Say Patients Need Not Panic
Reports link GLP-1 drugs like Ozempic and Wegovy to rare sudden vision loss called NAION, but doctors urge patients not to stop treatment without advice.
-
The Rise Of Unapproved GLP-1 Products And A Growing Patient Safety Concern
GLP-1 receptor agonists have transformed diabetes and obesity treatment, but high demand fuels a risky market for unapproved and counterfeit products.
-
Struggling With Asthma? New Study Says This Common Diabetes Drug May Reduce Severe Attacks By 40 Per Cent
The study has found that people with asthma who were prescribed semaglutide appeared to have nearly 40 per cent fewer asthma attacks compared to similar people taking another type of diabetes medicine.
-
Can GLP-1 Drugs Change Testosterone Levels? Doctor Explains
It found that total testosterone generally increased during GLP-1 therapy, particularly among men with obesity, type 2 diabetes or functional hypogonadism.
-
Obesity Drugs Show Early Promise Against The Hormonal Disorder PMOS, Giving A Suffering Family Hope
A small but growing body of research shows that these obesity medications may also work for the disorder known as PMOS — not only by promoting weight loss but also by improving insulin resistance, hormone balance and ovulation.
-
New Oral GLP-1 Pill Helps Adults Lose Up To 12% Weight, Finds Study
GLP-1 medicines have changed the treatment of obesity, but injections can be a barrier for some people. A daily pill could make treatment easier for people who are uncomfortable with injections.
-
Serena Williams Defends GLP-1 Weight-Loss Drug Use: What Doctors Want You To Know
Serena Williams used GLP-1 medication Zepbound to lose weight and improve health post-pregnancy, highlighting obesity treatment options.
-
Beyond Appetite: New Study Reveals How GLP-1 Changes How Food Actually Tastes
The researchers reviewed evidence from different studies to understand how GLP-1 receptor agonists influence eating behaviour. Rather than focusing only on taste, they examined every stage of the eating experience, from sensing flavours to how the brain responds to food.
-
US Woman Mistook Pregnancy Symptoms For Medication Side Effects, Welcomes Baby Boy Unexpectedly
MacDougall recalled taking several pregnancy tests shortly before giving birth, and all of them came back negative.
-
On GLP-1 Drugs? Lifestyle Expert Luke Coutinho Says 'You Could Be Losing More Than Fat'
According to Coutinho, people who lose weight quickly may lose not only fat but also muscle, strength, bone mass and functional capacity.
-
Why Are Indians Quitting Weight-Loss Drugs Despite Lower Prices?
Generic GLP-1 drugs are cheaper than ever, but many Indians aren't staying on treatment. Here's why doctors say retention, not affordability, is the real challenge.
-
Taking A Break? Study Finds Why Many GLP-1 Users Stop And Restart Their Medication
The findings provide insight into the challenges people face while using these medications and may help healthcare providers identify patients who need support to stay on treatment.
-
America's Most Talked-About Drug Has A Surprising Secret: 69% of GLP-1 Users Are Unlikely To Admit Taking It
While GLP-1 medications have become one of the most visible health trends in America, a report found that less than a third (31%) of current and former GLP-1 users are likely to admit to using one.
-
One Injection A Month For Weight Loss? Pfizer's New Obesity Drug Explained
The natural GLP-1 hormone survives in the body for only a few minutes before it is broken down. Drug developers overcome this limitation through advanced molecular engineering techniques.
-
Big Bang Theory's Mayim Bialik's GLP-1 Drug Experience Was A "Nightmare": What Happened
Bialik explained that she did not start taking a GLP-1 drug simply to lose weight. Instead, she hoped it might help with health issues that had affected her for years.
-
Ozempic, Wegovy And Zepbound May Cause Vision Loss? Indian Doctors Say Patients Need Not Panic
Reports link GLP-1 drugs like Ozempic and Wegovy to rare sudden vision loss called NAION, but doctors urge patients not to stop treatment without advice.
-
The Rise Of Unapproved GLP-1 Products And A Growing Patient Safety Concern
GLP-1 receptor agonists have transformed diabetes and obesity treatment, but high demand fuels a risky market for unapproved and counterfeit products.
-
Struggling With Asthma? New Study Says This Common Diabetes Drug May Reduce Severe Attacks By 40 Per Cent
The study has found that people with asthma who were prescribed semaglutide appeared to have nearly 40 per cent fewer asthma attacks compared to similar people taking another type of diabetes medicine.
-
Can GLP-1 Drugs Change Testosterone Levels? Doctor Explains
It found that total testosterone generally increased during GLP-1 therapy, particularly among men with obesity, type 2 diabetes or functional hypogonadism.
-
Obesity Drugs Show Early Promise Against The Hormonal Disorder PMOS, Giving A Suffering Family Hope
A small but growing body of research shows that these obesity medications may also work for the disorder known as PMOS — not only by promoting weight loss but also by improving insulin resistance, hormone balance and ovulation.
-
New Oral GLP-1 Pill Helps Adults Lose Up To 12% Weight, Finds Study
GLP-1 medicines have changed the treatment of obesity, but injections can be a barrier for some people. A daily pill could make treatment easier for people who are uncomfortable with injections.
-
Serena Williams Defends GLP-1 Weight-Loss Drug Use: What Doctors Want You To Know
Serena Williams used GLP-1 medication Zepbound to lose weight and improve health post-pregnancy, highlighting obesity treatment options.
-
Beyond Appetite: New Study Reveals How GLP-1 Changes How Food Actually Tastes
The researchers reviewed evidence from different studies to understand how GLP-1 receptor agonists influence eating behaviour. Rather than focusing only on taste, they examined every stage of the eating experience, from sensing flavours to how the brain responds to food.
-
US Woman Mistook Pregnancy Symptoms For Medication Side Effects, Welcomes Baby Boy Unexpectedly
MacDougall recalled taking several pregnancy tests shortly before giving birth, and all of them came back negative.
-
On GLP-1 Drugs? Lifestyle Expert Luke Coutinho Says 'You Could Be Losing More Than Fat'
According to Coutinho, people who lose weight quickly may lose not only fat but also muscle, strength, bone mass and functional capacity.
-
Why Are Indians Quitting Weight-Loss Drugs Despite Lower Prices?
Generic GLP-1 drugs are cheaper than ever, but many Indians aren't staying on treatment. Here's why doctors say retention, not affordability, is the real challenge.
-
Taking A Break? Study Finds Why Many GLP-1 Users Stop And Restart Their Medication
The findings provide insight into the challenges people face while using these medications and may help healthcare providers identify patients who need support to stay on treatment.
-
America's Most Talked-About Drug Has A Surprising Secret: 69% of GLP-1 Users Are Unlikely To Admit Taking It
While GLP-1 medications have become one of the most visible health trends in America, a report found that less than a third (31%) of current and former GLP-1 users are likely to admit to using one.
-
One Injection A Month For Weight Loss? Pfizer's New Obesity Drug Explained
The natural GLP-1 hormone survives in the body for only a few minutes before it is broken down. Drug developers overcome this limitation through advanced molecular engineering techniques.
-
Big Bang Theory's Mayim Bialik's GLP-1 Drug Experience Was A "Nightmare": What Happened
Bialik explained that she did not start taking a GLP-1 drug simply to lose weight. Instead, she hoped it might help with health issues that had affected her for years.
